Functional human Factor V has been purified using a rapid immunoaffinity method. Following barium citrate adsorption of plasma, Factor V was precipitated with polyethylene glycol at a concentration between 5 and 14%. The resulting preparation was applied to a column containing an immobilized immunoadsorbent consisting of an IgG fraction containing a naturally occurring human monoclonal (IgG4λ) antibody with inhibitory activity against human Factor V. The solid phase immunoglobulin quantitatively bound Factor V from human plasma. The bound Factor V was effectively eluted with a Tris buffer pH 7.2 containing 1.2 M NaCl and 1 M α-methyl-D-mannoside. The isolated native Factor V with high specific activity (92 U/mg) showed a single band (Mr, 350,000) on both reduced and nonreduced sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Factor V was purified 5,100-fold over plasma with an overall yield of 77%. The purified Factor V when subjected to thrombin activation exhibited an 18-fold increase in coagulant activity.
Hui Chong Chiu, Eugene Whitaker, Robert W. Colman
Title and authors | Publication | Year |
---|---|---|
The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation
PH Bolton-Maggs, DJ Perry, EA Chalmers, LA Parapia, JT Wilde, MD Williams, PW Collins, S Kitchen, G Dolan, AD Mumford |
Haemophilia | 2004 |
Report of a rare co-incidence of congenital factor V deficiency and thalassemia intermedia in a family
Yasser Abou Mourad, Ali Shamseddine, Ayad Hamdan, Susane Koussa, Ali Taher |
Annals of Saudi medicine | 2004 |